Technology

Ligand Pharmaceuticals

$162.94
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$6.08 (+3.88%) Today
$0.00 (0.00%) As of 11:06 AM UTC after-hours

Why Robinhood?

You can buy or sell LGND and other stocks, options, and ETFs commission-free!

About LGND

Ligand Pharmaceuticals Incorporated Common Stock, also called Ligand Pharmaceuticals, is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. The listed name for LGND is Ligand Pharmaceuticals Incorporated Common Stock.

CEO
John L. Higgins
Employees
115
Headquarters
San Diego, California
Founded
1987
Market Cap
2.61B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
1.16M
High Today
$198.79
Low Today
$153.92
Open Price
$170.00
Volume
5.58M
52 Week High
$198.79
52 Week Low
$57.24

Collections

LGND Earnings

$0.00
$0.35
$0.69
$1.04
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
Available Feb 3, Pre-Market

You May Also Like

JIH+
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure